争议事件
以下收录公开来源中与该品牌相关的争议事件。列出一条并不表示过错已经证实。
返回词条共 2 条
2021
AbbVie 对 Alvotech 提起第二起诉讼
提起诉讼
AbbVie 在伊利诺伊州北区对 Alvotech hf. 提起第二起诉讼，指控其涉及 Alvotech 拟议的 HUMIRA 生物类似药的专利侵权。
来源摘录
On May 28, AbbVie brought a second action in the Northern District of Illinois for patent infringement against Alvotech hf. under the BPCIA in connection with Alvotech’s proposed biosimilar version of HUMIRA® (adalimumab).
2021
Alvotech 就 Humira 专利起诉 AbbVie
提起诉讼
Alvotech USA 与 Alvotech hf 在弗吉尼亚东区法院对 AbbVie 提起确认判决诉讼，指称 AbbVie Humira 专利组合中的专利无效或不可执行，并请求法院作出不侵权及专利无效的确认判决。
来源摘录
For each patent, the complaint asserts a claim for a declaratory judgment of non-infringement and invalidity.
On May 11, 2021, Alvotech USA and Alvotech hf (jointly, Alvotech) filed a complaint seeking declaratory judgement against AbbVie Inc. and AbbVie Biotechnology Ltd (jointly, AbbVie) in the Eastern District of Virginia.